
    
      The study will include a total of 40 patients with calcified coronary lesions who will be
      randomised 1:1 to the treatment with IVL (Shockwave; Shockwave Medical, Inc, Santa Clara,
      USA) or the standard therapy (non-compliat high-pressure or Scoreflex predilatation,
      rotational atherectomy, etc). Appropriate preparation of the lesions will be followed by DES
      implantation.
    
  